Supplementary Material – Phase II, Clinical Trial of Cabozantinib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplant
收藏数据链接：
官方服务：
资源简介：
Allowed Therapies Prohibited or Restricted Therapies Biological specimens (Plans for collection, laboratory evaluation, and storage of specimens) Confidentiality Retention of Patient Records and Study Files
提供机构：
Future Science Group创建时间：
2022-05-03
